stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) EPS (diluted)
Stevanato Group S.p.A.'s EPS (diluted) for fiscal 2025 was $0.58, up 23.4% from $0.47 in fiscal 2024. Over the twelve months to 30 September 2026 it was $0.59. Over the past ten years it has ranged from $0.17 (fiscal 2019) to $0.63 (fiscal 2021); the current reading is higher than 71% of that period. Stevanato Group S.p.A. ranks 19th of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $0.58 | 23.40% |
| FY2024 | $0.47 | (21.67%) |
| FY2023 | $0.60 | 5.26% |
| FY2022 | $0.57 | (9.52%) |
| FY2021 | $0.63 | 68.77% |
| FY2020 | $0.37 | 119.59% |
| FY2019 | $0.17 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.18 | 95.89% |
| Jun 2026 | $0.09 | (25.00%) |
| Mar 2026 | $0.12 | (40.00%) |
| Dec 2025 | $0.20 | 33.33% |
| 22 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NVST Envista Holdings Corporation compare | $3.92 |
| MMSI Merit Medical Systems, Inc. compare | $2.66 |
| ICUI ICU Medical, Inc. compare | $2.39 |
| STVN Stevanato Group S.p.A. | $0.59 |
| ATRC AtriCure, Inc. compare | $0.30 |
| WRBY Warby Parker Inc. compare | $0.06 |
| MMED MiniMed Group, Inc. compare | −$0.59 |
| PLSE Pulse Biosciences, Inc compare | −$1.21 |
| TFX Teleflex Incorporated compare | −$23.29 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on STVN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement